Healthy horizons for global plasma industry

CSL rival and one-time takeover target Talecris Biotherapeutics has painted a rosy picture of the global blood plasma industry in a report to the US Securities and Exchange Commission, showing improving sales and gross margins for the world's No. 3 blood plasma supplier.